// App-Quantinova.ai

BSH19‐OR‐003 : CD200 blocking antibody restores immune functions and reduces disease levels in preclinical acute myeloid leukaemia models

Researchers

Presenter

  • N. Rastogi

Principal Investigators

  • F. Dos Anjos-Afonso

  • M. Wong

  • R.A. Uger

  • S. Knapper

  • R. Darley

  • A. Tonks

Medical Centers

  • Department of Hematology,

  • Wales Heart Research Institute, Cardiff University, Cardiff, United Kingdom

  • Trillium Therapeutics Inc., Mississauga, Ontario, Canada.

  • Department of Haematology, Cardiff University, School of Medicine, Cardiff, United Kingdom

Locations

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Natural Killer cells

  • Cluster of Differentiation 107 Antigen-Like Family Member A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved